Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Intellia Therapeutics, Inc. | Director | Common Stock | 26.7K | $881K | $32.99 | Jun 12, 2024 | Direct |
GRAIL, Inc. | Director | Common Stock | 26.5K | $430K | $16.25 | Jun 25, 2024 | Direct |
Intellia Therapeutics, Inc. | Director | Stock Option (right to buy) | 11.5K | Jun 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GRAL | GRAIL, Inc. | Jun 25, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
NTLA | Intellia Therapeutics, Inc. | Jun 12, 2024 | 2 | $0 | 4 | Jun 14, 2024 | Director |
GRAL | GRAIL, LLC | Jun 11, 2024 | 0 | $0 | 3 | Jun 11, 2024 | Director |
NTLA | Intellia Therapeutics, Inc. | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
NTLA | Intellia Therapeutics, Inc. | Apr 14, 2023 | 2 | $0 | 4 | Apr 18, 2023 | Director |
NTLA | Intellia Therapeutics, Inc. | Apr 14, 2023 | 0 | $0 | 3 | Apr 18, 2023 | Director |